1-4 of 4
Adam C. Lane
Close
Sort by
Journal Articles

Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusion Requirements in Ugandan Children with Sickle Cell Anemia: Baseline Data from the Alternative Dosing and Prevention of Transfusions (ADAPT) Trial

Alexandra Power-Hays, Ruth Namazzi, Charles Kato, Andrea Conroy, Heather Ann Hume, Chandy C. John, Susan E. Stuber, Adam C. Lane, Teresa S. Latham, Robert Opoka, Russell E. Ware
Journal: Blood
Blood (2023) 142 (Supplement 1): 1156.
https://doi.org/10.1182/blood-2023-181058
Published: 2023
Journal Articles

Prospective Identification of Variables As Outcomes for Treatment (PIVOT): A Phase II Clinical Trial of Hydroxyurea for Children and Adults with HbSC Disease

Catherine I. Segbefia, Luke R. Smart, Susan E. Stuber, Priscilla Ekpale, Kwesi N. Amissah-Arthur, Klenam Dzefi-Tettey, Enoch Mensah, Adam C. Lane, Diana Dwuma-Badu, Teresa S. Latham, Yvonne Dei-Adomakoh, Russell E. Ware
Journal: Blood
Blood (2023) 142 (Supplement 1): 3877.
https://doi.org/10.1182/blood-2023-190351
Published: 2023
Journal Articles

Emapalumab for Treatment of Impending Graft Failure

Anthony Sabulski, Sonata Jodele, Eleanor Cook, Kasiani Myers, Adam C. Lane, Samppa Ryhanen, Sr., Maria Pia Cefalo, Francesco Quagliarella, Stella M Davies, Ashley Teusink-Cross, Paibel Aguayo-Hiraldo, Jessie L. Alexander, Paul Szabolcs, Mira Kohorst, Tiziana Corsetti, Franco Locatelli, Pietro Merli
Journal: Blood
Blood (2023) 142 (Supplement 1): 114.
https://doi.org/10.1182/blood-2023-181096
Published: 2023
Journal Articles

Hydroxyurea Dose Optimization Is Safe and Improves Outcomes for Children with Sickle Cell Anemia Living in Sub-Saharan Africa: The Reach Experience

Banu Aygun, Adam C. Lane, Luke R. Smart, Leon Tshilolo, Thomas N. Williams, Peter Olupot-Olupot, Brigida Santos, Susan E. Stuber, George A. Tomlinson, Teresa S. Latham, Russell E. Ware
Journal: Blood
Blood (2023) 142 (Supplement 1): 6.
https://doi.org/10.1182/blood-2023-172919
Published: 2023